People on the Move
SynteractHCR
SynteractHCR, a Phase I-IV contract research organisation, has appointed three senior managers.
James Cappola will become US Medical Director. He has worked in clinical development for 25 years, including positions at Harvard Clinical Research Institute, Cephalon, BASF, Knoll Pharmaceutical, and TransTech Pharma.
Gary Urban is set to take over as Director of Quality Assurance. He will join the company from WCCT Global where he led corporate compliance and quality.
Barbara Falk will join SynteractHCR as Safety Surveillance Manager for EMEA. She has worked for the CROs Research Pharmaceutical Services and PRA Health Sciences. She will be based in Germany, working closely with the US team.